| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.33 | 2e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |